Your browser doesn't support javascript.
loading
Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics.
Menter, Alan; Strober, Bruce E; Kaplan, Daniel H; Kivelevitch, Dario; Prater, Elizabeth Farley; Stoff, Benjamin; Armstrong, April W; Connor, Cody; Cordoro, Kelly M; Davis, Dawn M R; Elewski, Boni E; Gelfand, Joel M; Gordon, Kenneth B; Gottlieb, Alice B; Kavanaugh, Arthur; Kiselica, Matthew; Korman, Neil J; Kroshinsky, Daniela; Lebwohl, Mark; Leonardi, Craig L; Lichten, Jason; Lim, Henry W; Mehta, Nehal N; Paller, Amy S; Parra, Sylvia L; Pathy, Arun L; Rupani, Reena N; Siegel, Michael; Wong, Emily B; Wu, Jashin J; Hariharan, Vidhya; Elmets, Craig A.
Afiliação
  • Menter A; Baylor Scott and White, Dallas, Texas.
  • Strober BE; University of Connecticut, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada.
  • Kaplan DH; University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Kivelevitch D; Baylor Scott and White, Dallas, Texas.
  • Prater EF; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
  • Stoff B; Emory University School of Medicine, Atlanta, Georgia.
  • Armstrong AW; University of Southern California, Los Angeles, San Francisco.
  • Connor C; University of Alabama, Birmingham, Alabama.
  • Cordoro KM; University of California, San Francisco School of Medicine, Department of Dermatology, San Francisco, California.
  • Davis DMR; Mayo Clinic, Rochester, Minnesota.
  • Elewski BE; University of Alabama, Birmingham, Alabama.
  • Gelfand JM; University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
  • Gordon KB; Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Gottlieb AB; Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York.
  • Kavanaugh A; University of California San Diego, San Diego, California.
  • Kiselica M; National Psoriasis Foundation, Portland, Oregon.
  • Korman NJ; University Hospitals Cleveland Medical Center, Cleveland, Ohio.
  • Kroshinsky D; Massachusetts General Hospital, Boston, Massachusetts.
  • Lebwohl M; Department of Dermatology, Icahn School of Medicine at Mt. Sinai, New York.
  • Leonardi CL; Central Dermatology, St. Louis, Missouri.
  • Lichten J; National Psoriasis Foundation, Portland, Oregon.
  • Lim HW; Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
  • Mehta NN; National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Paller AS; Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Parra SL; Dermatology and Skin Surgery, Sumter, South Carolina.
  • Pathy AL; Colorado Permanente Medical Group, Centennial, Colorado.
  • Rupani RN; Central Dermatology, St. Louis, Missouri.
  • Siegel M; National Psoriasis Foundation, Portland, Oregon.
  • Wong EB; San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio.
  • Wu JJ; Dermatology Research and Education Foundation, Irvine, California.
  • Hariharan V; American Academy of Dermatology, Rosemont, Illinois. Electronic address: vhariharan@aad.org.
  • Elmets CA; University of Alabama, Birmingham, Alabama.
J Am Acad Dermatol ; 80(4): 1029-1072, 2019 Apr.
Article em En | MEDLINE | ID: mdl-30772098
Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US population. This guideline addresses important clinical questions that arise in psoriasis management and care, providing recommendations based on the available evidence. The treatment of psoriasis with biologic agents will be reviewed, emphasizing treatment recommendations and the role of the dermatologist in monitoring and educating patients regarding benefits as well as associated risks.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos / Fármacos Dermatológicos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Psoríase / Produtos Biológicos / Fármacos Dermatológicos Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: J Am Acad Dermatol Ano de publicação: 2019 Tipo de documento: Article